This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2024
AMA 2024
ASCO 2024
AUA 2024
APCCC 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
AUA 2023
AUA 2023
Prostate Cancer
Testicular and Penile Cancer
Bladder Cancer
Stone Disease
Press Release
Kidney Cancer
Upper Tract Urothelial Carcinoma
AUA 2023 Prostate Cancer
Viewing 21-40 of 65 articles
AUA 2023: Biochemical Recurrence of Localized Prostate Cancer Originating From the Transition Versus Peripheral Zone: a Systematic Review and Meta-Analysis
AUA 2023: New Guidelines for Sexual Health Care with Prostate Cancer
AUA 2023: Debate: Renaming Gleason 6 Prostate Cancer
AUA 2023: Associations Between Prostate MRI and Genomic Testing and Treatment Intensification Among Patients with Localized Prostate Cancer
AUA 2023: Using the Negative Predictive Value and SUVmax of PSMA PET/CT for Avoiding Pelvic Lymph Node Dissection With Radical Prostatectomy
AUA 2023: SUVmax Of the Primary Prostate Lesion on the PSMA PET CT: an Indicator of Aggressive Pathology
AUA 2023: The Prognostic Impact of Preoperative PSMA-PET on Early Oncological Outcomes in Prostate Cancer Patients Treated With Radical Prostatectomy: Results of a Multi-center Analysis
AUA 2023: Updates on Clinical Trials in Prostate Cancer
AUA 2023: Germline Testing for Prostate Cancer in 2023 — Unlocking the Codes
AUA 2023: The Impact of Medicare Low-Income Subsidy on Access to Treatment, Treatment Choice, and Oncologic Outcomes in Patients with Metastatic Prostate Cancer
AUA 2023: Examining Testosterone Recovery in Androgen Deprivation Therapy for Prostate Cancer
AUA 2023: Real World Characterization of Patients Receiving Relugolix or Androgen Deprivation Therapy Injections in Combination with Oral Anti-Androgens in 2021 (The REAL ADT ORAL Study): Analysis from a US EMR Database
AUA 2023: Real-World Outcomes Among Men with Nonmetastatic Castration-sensitive Biochemical Recurrence After Definitive Therapy with Short PSA Doubling Time Receiving Early Secondary Treatment
AUA 2023: Far From the Truth: Real-world Treatment Patterns Among Newly Diagnosed Metastatic Prostate Cancer in the Era of Treatment Intensification
AUA 2023: Cost-Effectiveness of Systemic Treatment Intensification in Men With Metastatic Hormone-Sensitive Prostate Cancer
AUA 2023: Use of Decipher Prostate Biopsy Test in Men With Favorable Risk Disease Undergoing Conservative Management in the SEER Registry
AUA 2023: EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-Risk Biochemically Recurrent Prostate Cancer
AUA 2023: Treatment Pattern and HRQoL of Patients With mCRPC in the United States
AUA 2023: Multi-Institutional Analysis of Metastasis Directed Therapy With or Without ADT in Oligometastatic Castration Sensitive Prostate Cancer
AUA 2023: Efficacy and Feasibility of Additional Cycles of Docetaxel in Combination with Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free